These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32431191)

  • 21. Successful treatment with 308-nm monochromatic excimer light and subsequent tacrolimus 0.03% ointment in refractory plasma cell cheilitis.
    Yoshimura K; Nakano S; Tsuruta D; Ohata C; Hashimoto T
    J Dermatol; 2013 Jun; 40(6):471-4. PubMed ID: 23621817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis.
    Reitamo S; Rustin M; Ruzicka T; Cambazard F; Kalimo K; Friedmann PS; Schoepf E; Lahfa M; Diepgen TL; Judodihardjo H; Wollenberg A; Berth-Jones J; Bieber T;
    J Allergy Clin Immunol; 2002 Mar; 109(3):547-55. PubMed ID: 11898005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids.
    Poole CD; Chambers C; Allsopp R; Currie CJ
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):674-8. PubMed ID: 20565562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.
    Rice SA; Woo PN; El-Omar E; Keenan RA; Ormerod AD
    BMC Res Notes; 2013 Jan; 6():19. PubMed ID: 23331739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Paller AS; Stevens SR; Whitaker-Worth DL; Tong KB
    J Am Acad Dermatol; 2003 Apr; 48(4):553-63. PubMed ID: 12664019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study.
    Kroft EB; Groeneveld TJ; Seyger MM; de Jong EM
    Am J Clin Dermatol; 2009; 10(3):181-7. PubMed ID: 19354332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical tacrolimus in high-risk corneal transplants.
    Bernardes L; Gil J; Costa E; Tavares C; Rosa A; Quadrado MJ; Murta J
    Eur J Ophthalmol; 2024 Jan; 34(1):140-145. PubMed ID: 37128645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty.
    Dhaliwal JS; Mason BF; Kaufman SC
    Cornea; 2008 May; 27(4):488-93. PubMed ID: 18434855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis.
    Kymionis GD; Goldman D; Ide T; Yoo SH
    Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma cell cheilitis successfully treated with topical calcineurin inhibitors.
    Yamaguchi Y; Nishie W; Ito T; Shimizu H
    Eur J Dermatol; 2016 Dec; 26(6):609-610. PubMed ID: 27502182
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group.
    Reitamo S; Wollenberg A; Schöpf E; Perrot JL; Marks R; Ruzicka T; Christophers E; Kapp A; Lahfa M; Rubins A; Jablonska S; Rustin M
    Arch Dermatol; 2000 Aug; 136(8):999-1006. PubMed ID: 10926735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA; Kaufman HE; Insler M
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
    Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study.
    Zonneveld IM; Rubins A; Jablonska S; Dobozy A; Ruzicka T; Kind P; Dubertret L; Bos JD
    Arch Dermatol; 1998 Sep; 134(9):1101-2. PubMed ID: 9762021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
    Kroft EB; Erceg A; Maimets K; Vissers W; van der Valk PG; van de Kerkhof PC
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
    Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
    Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis.
    Kymionis GD; Kankariya VP; Kontadakis GA
    Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.